Arkolith/Insider Trading/RVMD/Form 4

Goldsmith Mark A

See Remarks, DirectorRevolution Medicines, Inc. (RVMD) · full profile →Form 4 · filed Apr 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$18.0M
Net Open-Market Flow
-$18.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)23K$4.09$95K300K
Apr 15, 2026Option exercise(M)97K$4.73$458K397K
Apr 15, 2026Sell(S)120K$150.09$18.0M277K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 15, 2026Option exercise(M)23K—$024K
Apr 15, 2026Option exercise(M)97K—$0424K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000146) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML